rs1554464495
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_006348.5(COG5):c.96delG(p.Cys33ValfsTer6) variant causes a frameshift, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,358 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_006348.5 frameshift, splice_region
Scores
Clinical Significance
Conservation
Publications
- COG5-congenital disorder of glycosylationInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COG5 | NM_006348.5 | c.96delG | p.Cys33ValfsTer6 | frameshift_variant, splice_region_variant | Exon 2 of 22 | ENST00000297135.9 | NP_006339.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COG5 | ENST00000297135.9 | c.96delG | p.Cys33ValfsTer6 | frameshift_variant, splice_region_variant | Exon 2 of 22 | 1 | NM_006348.5 | ENSP00000297135.4 | ||
| COG5 | ENST00000347053.8 | c.96delG | p.Cys33ValfsTer6 | frameshift_variant, splice_region_variant | Exon 2 of 21 | 1 | ENSP00000334703.3 | |||
| COG5 | ENST00000393603.7 | c.96delG | p.Cys33ValfsTer6 | frameshift_variant, splice_region_variant | Exon 2 of 21 | 1 | ENSP00000377228.3 | |||
| COG5 | ENST00000605888.1 | c.96delG | p.Cys33ValfsTer6 | frameshift_variant, splice_region_variant | Exon 2 of 6 | 2 | ENSP00000476238.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461358Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 726994 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
COG5-congenital disorder of glycosylation Pathogenic:2
This sequence change creates a premature translational stop signal (p.Cys64Valfs*6) in the COG5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COG5 are known to be pathogenic (PMID: 23228021). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 523949). This premature translational stop signal has been observed in individual(s) with COG5-congenital disorder of glycosylation (PMID: 23228021).
COG5-related disorder Pathogenic:1
The COG5 c.189delG variant is predicted to result in a frameshift and premature protein termination (p.Cys64Valfs*6). This variant has been reported in the compound heterozygous state in a patient with a congenital disorder of glycosylation (Patient 3, Rymen et al. 2012. PubMed ID: 2322802). To our knowledge, this variant has not been reported in the in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in COG5 are expected to be pathogenic. This variant is interpreted as likely pathogenic.
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 23228021)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at